Oral Supplementation of the Vitamin D Metabolite 25(OH)D<sub>3</sub> Against Influenza Virus Infection in Mice

Vitamin D is a fat-soluble vitamin that is metabolized by the liver into 25-hydroxyvitamin D [25(OH)D] and then by the kidney into 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D], which activates the vitamin D receptor expressed in various cells, including immune cells, for an overall im...

Full description

Bibliographic Details
Main Authors: Hirotaka Hayashi, Masatoshi Okamatsu, Honami Ogasawara, Naoko Tsugawa, Norikazu Isoda, Keita Matsuno, Yoshihiro Sakoda
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/7/2000
Description
Summary:Vitamin D is a fat-soluble vitamin that is metabolized by the liver into 25-hydroxyvitamin D [25(OH)D] and then by the kidney into 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D], which activates the vitamin D receptor expressed in various cells, including immune cells, for an overall immunostimulatory effect. Here, to investigate whether oral supplementation of 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>], a major form of vitamin D metabolite 25(OH)D, has a prophylactic effect on influenza A virus infection, mice were fed a diet containing a high dose of 25(OH)D<sub>3</sub> and were challenged with the influenza virus. In the lungs of 25(OH)D<sub>3</sub>-fed mice, the viral titers were significantly lower than in the lungs of standardly fed mice. Additionally, the proinflammatory cytokines IL-5 and IFN-γ were significantly downregulated after viral infection in 25(OH)D<sub>3</sub>-fed mice, while anti-inflammatory cytokines were not significantly upregulated. These results indicate that 25(OH)D<sub>3</sub> suppresses the production of inflammatory cytokines and reduces virus replication and clinical manifestations of influenza virus infection in a mouse model.
ISSN:2072-6643